Biosimilars and generics both lower drug costs, but they’re not the same. Biosimilars are complex biologic copies with different approval rules, safety considerations, and cost savings than simple generic chemicals.
Tag: biosimilars
Specialty pharmacies handle high-cost, complex drugs for chronic conditions. Generics and biosimilars offer major cost savings, but bring unique challenges in patient safety, PBM policies, and pharmacy workflows. Here’s what pharmacists need to know.